Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2
- PMID: 20221771
- DOI: 10.1007/s00415-010-5498-3
Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2
Abstract
The objective of this study was to determine the degree of brain involvement in a cohort of myotonic dystrophy type 1 and type 2 (DM1, DM2) patients by brain studies and functional tests and to compare the results of the two groups. DM1, DM2 are multisystemic disorders due to polynucleotide expansions. Previous studies on brain involvement by neuroimaging and functional methods have led to contradictory results. Fifty molecularly defined DM1 patients and 14 DM2 patients, were recruited for the study. Age at recruitment, age at disease onset, disease duration and educational level were recorded. Neuromuscular assessment was done by MIRS. An extensive neuropsychological battery was performed in 48/50 DM1 and in a control group of 44 healthy matched subjects. Forty six of 50 DM1 and 12/14 DM2 underwent brain MRI; 21/50 DM1 and 9/14 DM2 underwent brain perfusion SPECT, with semiquantitative analysis of the results. MRI images were classified by ARWMC (age-related white matter changes) score, in order to quantify recurrence, localization and patterns of distribution of white matter hyperintense lesions (WMHLs) in our two cohorts. MRI results were matched to SPECT and to neuropsychological results. Thirty-seven of 46 DM1 and 10/12 DM2 had abnormal MRI imaging, showing scattered supratentorial, bilateral, symmetrical focal or diffuse WMHLs. A typical temporo-insular diffuse subcortical pattern was seen in DM1 subjects only, with no correlation with cognitive involvement. Major cognitive involvement was seen in the case of diffuse frontal lesions. A relationship with CTG expansion size was documented for DM1 subjects. SPECT showed minimal hypoperfusion in the posterior cortex planes in DM1 and, to a lesser extent, in DM2. Very mild degrees of involvement in the DM2 cohort were seen. Neuroimaging and functional investigations confirmed a more severe involvement of the brain in DM1 compared to DM2. A temporo-insular diffuse lesional pattern, specific for DM1, was found on MRI. This confirms greater expansion size as a risk factor for more extensive brain involvement in DM1.
Similar articles
-
Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.PLoS One. 2015 Jun 26;10(6):e0130352. doi: 10.1371/journal.pone.0130352. eCollection 2015. PLoS One. 2015. PMID: 26114298 Free PMC article. Clinical Trial.
-
Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study.PLoS One. 2019 Mar 7;14(3):e0213381. doi: 10.1371/journal.pone.0213381. eCollection 2019. PLoS One. 2019. PMID: 30845252 Free PMC article.
-
Greater cortical thinning and microstructural integrity loss in myotonic dystrophy type 1 compared to myotonic dystrophy type 2.J Neurol. 2024 Aug;271(8):5525-5540. doi: 10.1007/s00415-024-12511-0. Epub 2024 Jun 19. J Neurol. 2024. PMID: 38896263 Free PMC article.
-
Neuropsychological Assessment Should Always be Considered in Myotonic Dystrophy Type 2.Cogn Behav Neurol. 2021 Mar 3;34(1):1-10. doi: 10.1097/WNN.0000000000000263. Cogn Behav Neurol. 2021. PMID: 33652465 Review.
-
Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.Acta Myol. 2013 Dec;32(3):154-65. Acta Myol. 2013. PMID: 24803843 Free PMC article. Review.
Cited by
-
Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.PLoS One. 2015 Jun 26;10(6):e0130352. doi: 10.1371/journal.pone.0130352. eCollection 2015. PLoS One. 2015. PMID: 26114298 Free PMC article. Clinical Trial.
-
Generation and Neuronal Differentiation of hiPSCs From Patients With Myotonic Dystrophy Type 2.Front Physiol. 2018 Jul 27;9:967. doi: 10.3389/fphys.2018.00967. eCollection 2018. Front Physiol. 2018. PMID: 30100878 Free PMC article.
-
Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1).J Neurol. 2022 Sep;269(9):5085-5092. doi: 10.1007/s00415-022-11165-0. Epub 2022 May 16. J Neurol. 2022. PMID: 35575811 Free PMC article.
-
Myotonic dystrophy type 2: the 2020 update.Acta Myol. 2020 Dec 1;39(4):222-234. doi: 10.36185/2532-1900-026. eCollection 2020 Dec. Acta Myol. 2020. PMID: 33458578 Free PMC article. Review.
-
Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.Orphanet J Rare Dis. 2016 Apr 4;11:34. doi: 10.1186/s13023-016-0417-z. Orphanet J Rare Dis. 2016. PMID: 27044540 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical